Authors: Morote, J Encabo, G de Torres, IM

Citation: J. Morote et al., Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancer, EUR UROL, 38(2), 2000, pp. 225-229

Authors: Morote, J Encabo, G Lopez, M de Torres, IM

Citation: J. Morote et al., Prediction of prostate volume based on total and free serum prostate-specific antigen: Is it reliable?, EUR UROL, 38(1), 2000, pp. 91-95

Authors: Morote, J Lopez, M Encabo, G de Torres, IM

Citation: J. Morote et al., Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen, EUR UROL, 37(5), 2000, pp. 537-540

Authors: Morote, J Raventos, CX Encabo, G Lopez, M de Torres, IM

Citation: J. Morote et al., Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigen, EUR UROL, 37(4), 2000, pp. 456-459

Authors: Morote, J Encabo, G Lopez, M de Torres, IM

Citation: J. Morote et al., Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage fi ee serum prostatic specific antigen, BJU INT, 84(6), 1999, pp. 657-660

Authors: Morote, J Encabo, G Lopez, MA de Torres, IM

Citation: J. Morote et al., The free-to-total serum prostatic specific antigen ratio as a predictor ofthe pathological features of prostate cancer, BJU INT, 83(9), 1999, pp. 1003-1006